💡 Can the U.S. lower drug prices by 30–80% while improving access and preserving innovation?
President Trump’s recent Executive Order lays the groundwork for bold reforms—targeting international price gaps, PBM markups, and regulatory delays.
This article applies a systems dynamics approach to identify leverage points and feedback loops driving high U.S. drug costs—and outlines concrete, policy-based strategies to reverse them.
Explore how systemic thinking can drive sustainable, scalable change in U.S. pharmaceutical pricing.
#SyenzaNews #DrugPricing #HealthcarePolicy #SystemsThinking #PharmaInnovation
